Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: Joe Dancy who wrote (470)	4/23/1998 5:29:00 PM
From: James Hutton	Respond to of 696

I also listened to the CC (over lunch), and you reported it pretty much correctly. I didn't note any over or under optimism. I think your statement regarding future revenues was correct. There was what has become the standard issue of currency problems, which cost the company approximately $250,000 in Q1. Also, in Q1 1997 there was some extra revenues from some project that had actually terminated in 1996. There was no mention, at least while I was listening, of the new CFO. US revenues were up 2%, again, because Japanese revenues in Q1 97, which are counted as US revenues, were unusually high in Q1 97. (it's hard to get a warm fuzzy when this year's flat revenues are justified because last year's were just too doggone high). Participants seemed very happy with cost controls and margins. I am cautiously optimistic, and if I might buy some shares here if I could only lower my already hefty margin account. I don't think the stock is going anywhere fast though. I think 20x .50 or $10 is a reasonable value for the stock, FWIW. Jon